How to read this section: We test whether three price-based signals —
12-month momentum (trailing stock return), realized volatility (annualized standard deviation of daily returns), and
relative strength (stock return minus S&P 500 return) — predict next-quarter fundamental outcomes:
revenue growth, operating margin change, and ROE change (all year-over-year to remove seasonality).
Each cell shows the Pearson correlation (r) between signal at quarter Q and outcome at quarter Q+1.
Values closer to +1 or −1 indicate stronger predictive relationships. “n” is the number of quarterly observations.
The examination of price‑based technical indicators versus fundamental outcomes for Beta Bionics, Inc. (BBNX) over the 2023Q3‑2026Q1 window reveals an absence of statistically reliable relationships. Across eleven quarterly observations, none of the three examined signals—12‑month momentum, realized volatility, or relative strength—demonstrated a meaningful correlation with revenue growth, margin change, or ROE change; every test suffered from insufficient sample size (n=1) and thus could not produce an r‑value or p‑value. Consequently, there is no evidence that price dynamics are leading indicators of the firm’s underlying financial performance in this period.
No price signal shows a statistically significant correlation with any fundamental metric for BBNX (all n=1, r and p not available).
The analysis period provides only eleven quarterly data points, limiting the ability to detect even moderate relationships (|r|≥0.4) with reasonable confidence.
Limitations: Sample size is extremely small (n=1 per test), making any correlation estimate unreliable and preventing significance testing. Potential regime shifts (e.g., clinical trial outcomes, regulatory events) could dominate price movements, obscuring any systematic signal‑fundamental link. Correlation does not imply causation; even if larger samples later reveal relationships, they may reflect concurrent market reactions rather than true predictive power.
BBNX
For Beta Bionics, the data set consists of a single observation per signal‑outcome pair, precluding any calculation of correlation coefficients. The lack of notable or strong signals means that momentum, volatility, and relative strength do not appear to forecast revenue growth, margin shifts, or changes in return on equity for this company within the examined horizon. While theoretically momentum could capture market participants’ expectations about future earnings, the empirical record here is too sparse to support such a linkage.